KUNZE JOHN H - 08 Aug 2026 Form 4 Insider Report for Ethos Technologies Inc. (LIFE)

Reporting relationship: Director
Issuer ticker: LIFE
Reported as of: 08 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 11 Aug 2026, 16:30:23 UTC
Prior SEC filing: 28 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Charlie York, Attorney-in-Fact

Key filing fact

KUNZE JOHN H filed Form 4 for Ethos Technologies Inc. (LIFE) on 11 Aug 2026.

Key facts

This page summarizes KUNZE JOHN H's Form 4 filing for Ethos Technologies Inc. (LIFE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 11 Aug 2026, 16:30.

Change

Previous filing in this sequence was filed on 28 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001032845 Primary reporting owner

KUNZE JOHN H

Relationship: Director
Address: C/O ETHOS TECHNOLOGIES INC., 1606 HEADWAY CIRCLE #9013, AUSTIN
Signature: /s/ Charlie York, Attorney-in-Fact
Signature date: 11 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LIFE transaction

Class A Common Stock

Award

Transaction value
Shares: +7,592
Change %: +31%
Price: $0.000000^*
Shares after: 31,785
Date: 08 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a restricted stock unit ("RSU") award. The RSUs will vest as to 25% on each of November 8, 2026, February 8, 2027, May 8, 2027 and August 8, 2027, provided, that the unvested portion of the RSU grant shall be fully vested on the earlier of (i) the first anniversary of the date of grant and (ii) the date of the Issuer's 2027 annual stockholder meeting, subject to the Reporting Person's continuous service through each such vesting date.

Footnote F2

Includes shares issuable on settlement of RSUs.